STAT1 and cancer: Genome-wide association studies reveal that common disease-associated polymorphisms are enriched in STAT1 promoter binding sites and that deregulated levels and/or activation of STAT1 are closely associated with the development of auto-immune/-inflammatory disorders and cancers [41].